Receipt of R&D Tax Incentive Rebate
Filed with ASX · · 1 page · English
Optiscan Imaging Limited (ASX: OIL) (‘the Company’ or ‘Optiscan’) is pleased to advise that the Company has received its R&D Tax Incentive rebate for the 2020/2021 financial year amounting to $770,283. The R&D Tax Incentive is an Australian Government program under which companies receive cash refunds for 43.5% of eligible expenditure on research and development. The R&D receivable amount to 30 Ju
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- OIL FY21 Annual Results Presentation
- Appendix 4E and 2021 Annual Report
- OIL June 2021 Quarterly Report and Appendix 4C
- Update on seeking United States FDA approval & market entry
- Appointment of new non-executive director
Later from Optiscan Imaging
- OIL September 2021 Quarterly Report and Appendix 4C
- Completion of imaging for Melbourne Breast cancer trial
- Change of Managing Director
- Appointment of Prof. Camile Farah as New CEO & Managing Director
- 2021 AGM Chairmans Address and MD Presentation
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging